140 related articles for article (PubMed ID: 36301324)
1. Benefit of [
OuYang PY; Liu ZQ; Lin QG; He Y; Guo ZX; Yao WY; Xu SK; Peng QH; Xiao SM; Li J; Li A; Zhang BY; Yang SS; Fan W; Xie CM; Wu YS; Zhang X; Chen CY; Xie FY
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):881-891. PubMed ID: 36301324
[TBL] [Abstract][Full Text] [Related]
2. Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Yang SS; Wu YS; Chen WC; Zhang J; Xiao SM; Zhang BY; Liu ZQ; Chen EN; Zhang X; OuYang PY; Xie FY
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):980-991. PubMed ID: 34468782
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pre-treatment [
Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
5. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
[TBL] [Abstract][Full Text] [Related]
6. Head and neck MRI-based T stage and [
Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: An update evidence from 44 studies.
Li Z; Li Y; Li N; Shen L
Cancer Med; 2019 Jan; 8(1):67-79. PubMed ID: 30578604
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma.
Yang SS; Wu YS; Pang YJ; Xiao SM; Zhang BY; Liu ZQ; Chen EN; Zhang X; OuYang PY; Xie FY
Eur Radiol; 2022 Jun; 32(6):3649-3660. PubMed ID: 34989842
[TBL] [Abstract][Full Text] [Related]
10. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Wei J; Pei S; Zhu X
Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of simultaneous whole-body
Chan SC; Yeh CH; Yen TC; Ng SH; Chang JT; Lin CY; Yen-Ming T; Fan KH; Huang BS; Hsu CL; Chang KP; Wang HM; Liao CT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1297-1308. PubMed ID: 29502310
[TBL] [Abstract][Full Text] [Related]
14. Comparison of diffusion-weighted MR imaging and
Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
Li C; Yang Y; Hu F; Xu Y; Wu B; Huang J; Yang K; Lan X
Clin Nucl Med; 2023 Jul; 48(7):563-573. PubMed ID: 37115936
[TBL] [Abstract][Full Text] [Related]
18. Significant value of
Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images.
Du D; Feng H; Lv W; Ashrafinia S; Yuan Q; Wang Q; Yang W; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2020 Jun; 22(3):730-738. PubMed ID: 31338709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]